Seeking Alpha
搜索文档
Morgan Stanley Keeps Pushing
Seeking Alpha· 2026-01-16 03:05
文章核心观点 - 文章核心为推广BAD BEAT Investing投资服务 该服务由Quad 7 Capital团队运营 提供短期和中期投资交易策略与教学 并提及摩根士丹利股票作为其交易案例之一 [1] 行业与市场环境 - 2025年是银行业表现优异的一年 主要银行正在陆续发布2025年第四季度财报 [1] - Quad 7 Capital团队以在2020年2月呼吁卖出一切并做空而闻名 自2020年5月以来平均保持95%多头和5%空头仓位 [1] 公司/服务介绍 - BAD BEAT Investing服务由Quad 7 Capital团队提供 该团队拥有7名分析师 具备商业 政策 经济学 数学 博弈论和科学等多领域专业知识 [1] - 该团队分享投资机会已近12年 专注于短期和中期投资 收益创造 特殊情况和动量交易 [1] - 服务提供每周深入研究后的书面交易想法 4个聊天室 每日免费的关键分析师升级/降级总结 基础期权交易教学以及广泛的交易工具 [1] - 服务推广价格为期55%折扣 从199美元降至87美元 [1] 分析师持仓与声明 - 分析师披露其通过股票 期权或其他衍生品持有摩根士丹利的受益多头头寸 [1]
Talkspace, Inc. (TALK) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:TALK) 2026-01-15
Seeking Alpha· 2026-01-16 03:01
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
BE Semiconductor: This Chip Packaging Leader Could Win From AI Memory Shortage
Seeking Alpha· 2026-01-16 02:57
文章核心观点 - 文章作者是一位航空航天、国防和航空业分析师,其目标是发现该行业的投资机会 [2] - 分析基于数据驱动的分析,并提供对数据分析监测平台的直接访问 [2] 作者与服务机构 - 作者拥有航空航天工程背景,为具有显著增长前景的复杂行业提供分析 [2] - 作者运营名为“航空航天论坛”的投资研究小组,该论坛是Seeking Alpha上排名第一的航空航天、国防和航空投资研究服务 [1] - 该服务提供对evoX数据分析平台的访问,这是一个内部开发的数据分析平台 [1]
Campbell's: Buy This 6% Yield While Market Ignores Value
Seeking Alpha· 2026-01-16 02:56
iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.It’s no secret that consumer staples stocks are trading in the doldrums and even big names like General Mills ( GIS ) and Kraft Heinz ( KHC ) are not immune. ...
Atea Pharmaceuticals, Inc. (AVIR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha· 2026-01-16 02:55
公司核心进展 - 公司正在分享其bemnifosbuvir和rizasvir联合疗法的最新进展 该疗法正处于治疗丙型肝炎的全球III期阶段 同时也在分享其治疗戊型肝炎新项目的新数据 [2] - 公司在执行其治疗丙型肝炎的全球III期项目方面表现完美 这使2026年成为公司的关键一年 [3] 丙肝项目临床进展 - 公司发现bemnifosbuvir已约7年 并对其首项试验C-BEYOND的数据即将在约6个月内出炉感到兴奋 这是一项北美试验 [3] - 公司于上月宣布C-BEYOND试验已完成入组 实际入组患者超过900名 预计首批数据将于2026年中 即今年第三季度获得 [3] - 公司的第二项III期临床试验C-FORWARD也按计划进行中 [4]
Lam Research: Why The WFE Supercycle Changes The Valuation (Upgrade) (NASDAQ:LRCX)
Seeking Alpha· 2026-01-16 02:51
If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Lam Research Corporation ( LRCX ) surged 8.3% in pre-market trading following a report from Stifel outlining expectations that wafer fabrication spending would increase 10-15% this year, up from prior expectations of 7-8%. I covered Lam Research in ...
Lam Research: Why The WFE Supercycle Changes The Valuation (Rating Upgrade)
Seeking Alpha· 2026-01-16 02:51
文章核心观点 - 投资研究机构Stifel的报告上调了对今年晶圆制造设备支出的预期 这直接推动了半导体设备公司Lam Research Corporation的股价在盘前交易中大幅上涨[2] 公司表现与事件 - Lam Research Corporation的股价在盘前交易中飙升8.3%[2] - 股价上涨的直接催化剂是Stifel发布的一份报告[2] 行业预期变化 - Stifel报告将今年晶圆制造设备支出的增长预期从原先的7-8%上调至10-15%[2] - 预期的上调幅度显著 增加了3至7个百分点[2]
AAII Sentiment Survey: Bullish Sentiment Jumps
Seeking Alpha· 2026-01-16 02:41
文章作者与背景 - 文章作者为Charles Rotblut,CFA,他是美国个人投资者协会旗舰刊物《AAII期刊》的编辑 [1] - 作者提供个人投资者情绪洞察和市场分析,并著有投资相关书籍 [1] 分析师披露 - 分析师声明其未持有任何提及公司的股票、期权或类似衍生品头寸,且在未来72小时内无计划建立任何此类头寸 [2] - 分析师表示文章为个人所写,表达个人观点,未因此获得报酬,且与任何提及股票的公司无业务关系 [2] 平台免责声明 - 平台声明过往表现不保证未来结果,所提供内容不构成针对任何特定投资者的投资建议 [3] - 平台声明所表达观点可能不代表Seeking Alpha整体立场,且平台本身并非持牌证券交易商、经纪商或美国投资顾问/投资银行 [3] - 平台分析师为第三方作者,包括可能未经任何机构或监管机构许可或认证的专业投资者和个人投资者 [3]
Gambling.Com Group: Dirt Cheap Pick-And-Shovel Gambling Growth Play
Seeking Alpha· 2026-01-16 02:36
Editor's note: Seeking Alpha is proud to welcome Liam Tormey as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.I am an American individual investor based in Taipei, Taiwan, where I have worked remotely in E-commerce for over a decade. I invest in mispriced mediocre to great companies with ethical management across all markets insisting on a healthy marg ...
Carl Zeiss Meditec - Why This Company Is A Good Choice For 2026. (OTCMKTS:CZMWF)
Seeking Alpha· 2026-01-16 02:30
Some investments that I make take a long time to mature. Some even take years - and if you're a value investor like I am, you have to kind of decide whether you'll allow companies to take as long as that to "mature". I argue thatAnalyst’s Disclosure:I/we have a beneficial long position in the shares of SEMHF, CZMWF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha ...